Daniel Salain

Daniel Salain currently works at Recall Therapeutics, Inc., as President & Director and Aceragen, Inc. (North Carolina), as Chief Operating Officer from 2020.
Mr. Salain also formerly worked at Idera Pharmaceuticals, Inc., as Chief Operating Officer, Aptalis Pharma LLC, as Vice President-Global Supply Chain & Manufacturing from 1999 to 2014, Graybug Vision, Inc., as Chief Operations & Technology Officer from 2019 to 2020, IVERIC bio, Inc., as Senior Vice President-Technical Operations from 2015 to 2017, Eurand Pharmaceuticals, Inc., as Vice President-Operations, and Aceragen, Inc., as Chief Operating Officer from 2020 to 2023.
Mr. Salain received his undergraduate degree from the University of Indianapolis.